Maastricht UMC+-Pulmonary disease ( Site 1602)

Maastricht, Limburg 6229 HX

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Carcinoma

Studies at this site

• Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008) — Running, not enrolling